Related Experiment Videos
[Pathophysiological bases of unstable coronary syndrome]
1Abteilung Innere Medizin II (Kardiologie, Angiologie, Pulmonologie, Nephrologie), Universitätsklinikum Ulm. johannes.waltenberger@medizin.uni-ulm.de
Insights
Acute coronary syndrome arises from complex plaque rupture. Understanding inflammation and angiogenesis is key to developing new therapies beyond current antithrombotic strategies.
Area of Science:
- Cardiovascular Medicine
- Pathology
- Immunology
Background:
- Acute coronary syndrome (ACS) results from atherosclerotic plaque rupture, leading to myocardial ischemia.
- The underlying atherosclerotic lesions and plaque instability mechanisms are complex.
- No established animal model exists for studying ACS processes.
Purpose of the Study:
- To explore the complex mechanisms triggering acute coronary syndrome.
- To identify key molecular and cellular processes involved in plaque vulnerability.
- To discuss potential therapeutic strategies for stabilizing vulnerable plaques.
Main Methods:
- Analysis of pathomorphological criteria for vulnerable plaques.
- Review of clinical studies on the thrombotic component of ACS.
- Investigation of inflammatory pathways, cytokines, and immune cells in plaque instability.
- Examination of plaque-angiogenesis and its role in destabilization.
Main Results:
- Vulnerable plaque characteristics have been identified through pathomorphological analysis.
- Clinical studies highlight the importance of the thrombotic component in ACS.
- Local inflammation, involving cytokines and immune components, is a key trigger.
- Plaque-angiogenesis contributes to matrix destabilization and potential rupture.
- C-reactive protein links systemic inflammation to early atherosclerotic lesions.
Conclusions:
- Inflammation and plaque-angiogenesis are critical in triggering ACS.
- Molecular strategies targeting matrix metalloproteinases and angiogenesis show promise for plaque stabilization.
- Current therapeutic options primarily rely on antithrombotic and anti-inflammatory approaches.
Background:
The acute coronary syndrome is the manifestation of a plaque rupture in a coronary artery, which can lead to intermittent or prolonged regional myocardial ischemia. In such a situation, the underlying atherosclerotic lesion is a complex one. Moreover, the mechanisms leading to the instability of an atherosclerotic plaque are complex themselves. This makes it problematic to systematically analyze the nature of the acute coronary syndrome. Moreover, no animal model is available to study this process.
Pathomorphological And Clinical Studies:
Substantial insights into the basis of the acute coronary syndrome have been gathered by pathomorphological analyses, which have helped to identify a number of criteria describing a vulnerable plaque. Clinical studies have helped to identify the thrombotic component as an important aspect of the clinical manifestation of the acute coronary syndrome. Based on such data, well-defined antithrombotic strategies play an important role in today's therapy of the acute coronary syndrome.
Triggering Mechanisms:
Concerning the triggering mechanisms for an acute coronary syndrome, there is a number of suspected processes, the most important of which is local inflammation of the coronary plaque. Inflammatory processes have recently been recognized as important stimulators of vascular modeling during atherogenesis. These inflammatory mechanisms involve a number of different cytokines, cells of the immune system and other components of the immune systems such as the complement cascade. C-reactive protein may even be a link between systemic and local inflammatory processes, because it has been shown to be systemically elevated in patients with unstable angina, and--most recently--has been shown to be involved in the initiation and progression of early atherosclerotic lesions. Local inflammation of the atherosclerotic plaques induces the expression of a number of growth factors and other potent molecules that contribute to vascular remodeling. These substances are acting on smooth muscle cells, fibroblasts as well as on the extracellular matrix and include growth factors, matrixmetalloproteinases and tissue inhibitors of metalloproteinase. Another component of potential significance within the unstable plaque is the process called plaque-angiogenesis. Plaque-angiogenesis occurs within complicated atherosclerotic plaques, the process of angiogenesis leads to destabilization of the extracellular matrix and, moreover, newly formed capillaries are more likely to rupture and may therefore be an important trigger of plaque rupture and of the acute coronary syndrome.
Therapeutic Approaches:
A number of molecular strategies including inhibition of matrix metalloproteinasis or inhibitors of angiogenesis may turn out to stabilize the vulnerable plaque. Until these therapeutic concepts may be used in the clinic, our therapeutic repertoire will mostly consist of antithrombotic and entire antiinflammatory approaches.